- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00534729
Organ Preservation: Weekly Carboplatin & Taxol w/Concurrent RT for Locally Advanced Laryngeal & Hypopharyngeal CA
February 28, 2019 updated by: King Faisal Specialist Hospital & Research Center
Organ Preservation: Weekly Carboplatin & Taxol w/concurrent RT for locally advanced laryngeal & Hypopharyngeal CA
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
200
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Riyadh, Saudi Arabia, 1211
- KFSH&RC
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients with locally advanced laryngeal & Hypopharyngeal CA
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
safety
Time Frame: 5 years
|
5 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Nasser Al-Rajhi, MD, KFSH&RC
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2007
Primary Completion (ACTUAL)
September 1, 2015
Study Completion (ACTUAL)
September 1, 2015
Study Registration Dates
First Submitted
September 21, 2007
First Submitted That Met QC Criteria
September 24, 2007
First Posted (ESTIMATE)
September 26, 2007
Study Record Updates
Last Update Posted (ACTUAL)
March 1, 2019
Last Update Submitted That Met QC Criteria
February 28, 2019
Last Verified
January 1, 2016
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Respiratory Tract Diseases
- Neoplasms by Site
- Respiratory Tract Neoplasms
- Pharyngeal Neoplasms
- Otorhinolaryngologic Neoplasms
- Head and Neck Neoplasms
- Pharyngeal Diseases
- Stomatognathic Diseases
- Otorhinolaryngologic Diseases
- Laryngeal Diseases
- Neoplasms
- Laryngeal Neoplasms
- Hypopharyngeal Neoplasms
- Antineoplastic Agents
- Carboplatin
Other Study ID Numbers
- RAC#0971-024
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypopharyngeal Neoplasms
-
Eye & ENT Hospital of Fudan UniversityNot yet recruitingLocally Advanced Hypopharyngeal CarcinomaChina
-
Chinese PLA General HospitalRecruiting
-
Samsung Medical CenterCompletedHypopharyngeal CancerKorea, Republic of
-
Sun Yat-sen UniversityRecruitingHypopharyngeal Cancer | Immunotherapy | Induction ChemotherapyChina
-
Sohag UniversityNot yet recruitingNasopharyngeal and Hypopharyngeal CarcinomaEgypt
-
Sun Yat-sen UniversityRecruitingHypopharyngeal CancerChina
-
University Hospital OstravaRecruitingLaryngeal Disease | Laryngeal Lesions | Hypopharyngeal Lesions | Suspected Laryngeal Cancer | Suspected Hypopharyngeal Cancer | Proven Laryngeal Cancer | Proven Hypopharyngeal CancerCzechia
-
Hospices Civils de LyonCompletedHypopharyngeal Carcinoma | Laryngeal CarcinomaFrance
-
University of Alabama at BirminghamCompletedHead and Neck Cancer | Hypopharyngeal Cancer | Oropharyngeal Cancer | Upper Aerodigestive Tract NeoplasmsUnited States
-
The Second People's Hospital of SichuanBiotech Pharmaceutical Co., Ltd.UnknownHypopharyngeal Cancer | Oropharyngeal CancerChina
Clinical Trials on Weekly Carboplatin & Taxol w/concurrent RT
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG Oncology; Cancer and Leukemia Group B; North...CompletedLung Cancer | Radiation ToxicityUnited States, Canada
-
Leiden UniversityCancer Research UK; NCIC Clinical Trials Group; Mario Negri Institute for Pharmacological... and other collaboratorsActive, not recruitingRandomized Trial of Radiation Therapy With or Without Chemotherapy for Endometrial Cancer (PORTEC-3)Endometrial CancerNetherlands
-
Women's Cancer Care Associates, LLCCompletedEndometrial Clear Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Stage IIIA Uterine Corpus Cancer | Stage IIIB Uterine Corpus Cancer | Stage IIIC Uterine Corpus Cancer | Stage IVA Uterine Corpus CancerUnited States, Canada
-
Spanish Lung Cancer GroupAventis PharmaceuticalsCompleted
-
Instituto do Cancer do Estado de São PauloWithdrawnBreast Cancer | HER-2 Positive Breast CancerBrazil
-
Fox Chase Cancer CenterAstraZenecaCompletedCancer of the Esophagus | Adenocarcinoma of the Gastroesophageal Junction | Cancer of the StomachUnited States
-
M.D. Anderson Cancer CenterUnited States Department of Defense; Genentech, Inc.CompletedNon-Small Cell Lung Cancer | Lung CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Completed
-
NRG OncologyNational Cancer Institute (NCI)RecruitingClinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Unresectable Gastroesophageal Junction Adenocarcinoma | Postneoadjuvant Therapy Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedGastroesophageal Junction Adenocarcinoma | Stage IIA Esophageal Cancer AJCC v7 | Stage IIB Esophageal Cancer AJCC v7 | Stage IIIA Esophageal Cancer AJCC v7 | Stage IIIB Esophageal Cancer AJCC v7 | Stage IIIC Esophageal Cancer AJCC v7 | Malignant Neoplasm of the Cervical Esophagus | Malignant Neoplasm...United States